Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 314.4K | 861.4K | 1.1M | 614.5K |
Selling general and admin | 1.5M | 1.6M | 1.0M | 1.1M |
Other operating expenses | — | — | — | — |
Operating income | -1.8M | -2.4M | -2.1M | -1.7M |
Non operating interest income | ||||
Income | 21.4K | — | — | 39.4K |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -1.8M | -2.4M | -2.0M | -1.7M |
Tax provision | — | — | — | — |
Net income | -1.8M | -2.4M | -2.0M | -1.7M |
Basic EPS | -0.1 | — | -0.1 | -0.1 |
Diluted EPS | -0.1 | — | -0.1 | -0.1 |
Basic average shares | 16.6M | — | 15.1M | 14.8M |
Diluted average shares | 16.6M | — | 15.1M | 14.8M |
EBITDA | -1.8M | -2.4M | -2.1M | -1.7M |
Net income from continuing op. | -1.8M | -2.4M | -2.0M | -1.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |